CPRX
CATALYST PHARMACEUTICALS, INC. · Healthcare
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$1.8M
reported sales (SEC code S)
Unique Insiders
3
in the rolling window
Latest filing
Jul 17, 2026
Harper Molly
CATALYST PHARMACEUTICALS, INC. (CPRX) has 50 SEC Form 4 filings (73 transaction rows) in the rolling window, disclosed by 3 distinct insiders. Most recent filing: Jul 17, 2026.
Inside the rolling window, 3 insiders at CATALYST PHARMACEUTICALS, INC. reported no open-market purchases and 3 open-market sales totaling $1.8M. The most recent open-market filing is a sale of 26,746 shares by Director Harper Molly, dated Dec 12, 2025, worth $622K.
- Industry:Biotechnology
- CEO:Richard John Daly
- Employees:182
- HQ:Coral Gables, FL, US
- IPO:2006-11-08
| Source | |||||||
|---|---|---|---|---|---|---|---|
Harper MollyFirst filing | Director | Sale | 26,746 | $622K | Dec 16 | +30.2% | SEC ↗ |
Del Carmen JeffreyFirst filing | Chief Commercial Officer | Sale | 10,983 | $256K | Nov 28 | +34.5% | SEC ↗ |
Elsbernd BrianFirst filing | Chief Compliance/Legal Officer | Sale | 40,000 | $908K | Nov 14 | +35.8% | SEC ↗ |
Earnings: last 7 quarters
Frequently asked questions
How many SEC Form 4 insider filings does CPRX have?
CATALYST PHARMACEUTICALS, INC. (CPRX) has 50 SEC Form 4 filings (73 transaction rows) in the rolling 365-day window, disclosed by 3 distinct insiders. Most recent filing: Jul 17, 2026.
When was the most recent SEC Form 4 filing for CPRX?
The most recent Form 4 filing for CPRX on Tracefour is dated Jul 17, 2026.
What is the total insider buy and sell value at CPRX in the current window?
Inside the rolling window, insiders at CPRX bought $0 and sold $1.8M based on SEC Form 4 filings.
Can I get alerts for CPRX insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at CATALYST PHARMACEUTICALS, INC. (CPRX). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
CATALYST PHARMACEUTICALS, INC. is in the Healthcare sector.